Innate and adaptive immune dysregulation in critically ill ICU patients-Reference-Cited by-同舟云学术

Innate and adaptive immune dysregulation in critically ill ICU patients

Published:2018-07-05 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Duggal Niharika Arora,Snelson Catherine,Shaheen Ulfath,Pearce Victoria,Lord Janet M.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-28409-7.pdf

Reference55 articles.

1. Hospital Episode Statistics Analysis H. Adult Critical Care in England - April 2013 to March 2014. Health and Social Care Information Centre. (2015).

2. Xiao, W. et al. A genomic storm in critically injured humans. J Exp Med. 208, 2581–90 (2011).

3. Brun-Buisson, C. The epidemiology of the systemic inflammatory response. Intensive Care Med. 26, 64–74 (2000).

4. Adib-Conquy, M. & Cavaillon, J. M. Compensatory anti-inflammatory response syndrome. Thromb Haemost. 101, 36–47 (2009).

5. Boomer, J. S. et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 306, 2594–605 (2011).

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiopulmonary bypass and VA-ECMO induced immune dysfunction: common features and differences, a narrative review;Critical Care;2024-09-10

2. Carbapenem-resistant Enterobacterales sepsis following endoscopic retrograde cholangiopancreatography: risk factors for 30-day all-cause mortality and the development of a nomogram based on a retrospective cohort;Antimicrobial Resistance & Infection Control;2024-08-07

3. Pathogenesis and therapeutic opportunities of gut microbiome dysbiosis in critical illness;Gut Microbes;2024-05-23

4. Persistent Inflammation, Immunosuppression, and Catabolism Syndrome in Pediatric Populations: A Brief Perspective;Current Pediatric Reviews;2024-05-14

5. Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial;The Lancet Respiratory Medicine;2024-05